Cargando…
Unguided De-Escalation Strategy From Potent P2Y(12) Inhibitors in Patients Presented With ACS: When, Whom and How?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Society of Cardiology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989794/ https://www.ncbi.nlm.nih.gov/pubmed/35388998 http://dx.doi.org/10.4070/kcj.2022.0022 |
| _version_ | 1784683249058971648 |
|---|---|
| author | Park, Jin Sup Jeong, Young-Hoon |
| author_facet | Park, Jin Sup Jeong, Young-Hoon |
| author_sort | Park, Jin Sup |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8989794 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The Korean Society of Cardiology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89897942022-04-18 Unguided De-Escalation Strategy From Potent P2Y(12) Inhibitors in Patients Presented With ACS: When, Whom and How? Park, Jin Sup Jeong, Young-Hoon Korean Circ J Editorial The Korean Society of Cardiology 2022-02-25 /pmc/articles/PMC8989794/ /pubmed/35388998 http://dx.doi.org/10.4070/kcj.2022.0022 Text en Copyright © 2022. The Korean Society of Cardiology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Park, Jin Sup Jeong, Young-Hoon Unguided De-Escalation Strategy From Potent P2Y(12) Inhibitors in Patients Presented With ACS: When, Whom and How? |
| title | Unguided De-Escalation Strategy From Potent P2Y(12) Inhibitors in Patients Presented With ACS: When, Whom and How? |
| title_full | Unguided De-Escalation Strategy From Potent P2Y(12) Inhibitors in Patients Presented With ACS: When, Whom and How? |
| title_fullStr | Unguided De-Escalation Strategy From Potent P2Y(12) Inhibitors in Patients Presented With ACS: When, Whom and How? |
| title_full_unstemmed | Unguided De-Escalation Strategy From Potent P2Y(12) Inhibitors in Patients Presented With ACS: When, Whom and How? |
| title_short | Unguided De-Escalation Strategy From Potent P2Y(12) Inhibitors in Patients Presented With ACS: When, Whom and How? |
| title_sort | unguided de-escalation strategy from potent p2y(12) inhibitors in patients presented with acs: when, whom and how? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989794/ https://www.ncbi.nlm.nih.gov/pubmed/35388998 http://dx.doi.org/10.4070/kcj.2022.0022 |
| work_keys_str_mv | AT parkjinsup unguideddeescalationstrategyfrompotentp2y12inhibitorsinpatientspresentedwithacswhenwhomandhow AT jeongyounghoon unguideddeescalationstrategyfrompotentp2y12inhibitorsinpatientspresentedwithacswhenwhomandhow |